Effect of evolocumab on saphenous vein graft patency after coronary artery bypass surgery (NEWTON-CABG CardioLink-5): an international, randomised, double-blind, placebo-controlled trial

Subodh Verma, Lawrence A Leiter, Hwee Teoh, G B John Mancini, Adrian Quan, Randi Elituv, Meena Verma, Elizabeth Misner, Michael Szarek, Kevin E Thorpe, Tarit Saha, Richard P Whitlock, Bobby Yanagawa, Béla Merkely, Peter Jüni, Michael J Koren, Stephen J Nicholls, Deepak L Bhatt, C David Mazer

Open source

DOI: 10.1016/s0140-6736(25)01633-2
Published: 2025-09
Container: The Lancet
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s0140-6736-25-01633-2,
  title = {Effect of evolocumab on saphenous vein graft patency after coronary artery bypass surgery (NEWTON-CABG CardioLink-5): an international, randomised, double-blind, placebo-controlled trial},
  author = {Subodh Verma and Lawrence A Leiter and Hwee Teoh and G B John Mancini and Adrian Quan and Randi Elituv and Meena Verma and Elizabeth Misner and Michael Szarek and Kevin E Thorpe and Tarit Saha and Richard P Whitlock and Bobby Yanagawa and Béla Merkely and Peter Jüni and Michael J Koren and Stephen J Nicholls and Deepak L Bhatt and C David Mazer},
  year = {2025},
  journal = {The Lancet},
  doi = {10.1016/s0140-6736(25)01633-2},
  url = {https://doi.org/10.1016/s0140-6736(25)01633-2}
}

RIS

TY  - JOUR
TI  - Effect of evolocumab on saphenous vein graft patency after coronary artery bypass surgery (NEWTON-CABG CardioLink-5): an international, randomised, double-blind, placebo-controlled trial
AU  - Subodh Verma
AU  - Lawrence A Leiter
AU  - Hwee Teoh
AU  - G B John Mancini
AU  - Adrian Quan
AU  - Randi Elituv
AU  - Meena Verma
AU  - Elizabeth Misner
AU  - Michael Szarek
AU  - Kevin E Thorpe
AU  - Tarit Saha
AU  - Richard P Whitlock
AU  - Bobby Yanagawa
AU  - Béla Merkely
AU  - Peter Jüni
AU  - Michael J Koren
AU  - Stephen J Nicholls
AU  - Deepak L Bhatt
AU  - C David Mazer
PY  - 2025
JO  - The Lancet
DO  - 10.1016/s0140-6736(25)01633-2
UR  - https://doi.org/10.1016/s0140-6736(25)01633-2
ER  -

APA

Verma, S., Leiter, L. A., Teoh, H., Mancini, G. B. J., Quan, A., Elituv, R., Verma, M., Misner, E., Szarek, M., Thorpe, K. E., Saha, T., Whitlock, R. P., Yanagawa, B., Merkely, B., Jüni, P., Koren, M. J., Nicholls, S. J., Bhatt, D. L., & Mazer, C. D. (2025). Effect of evolocumab on saphenous vein graft patency after coronary artery bypass surgery (NEWTON-CABG CardioLink-5): an international, randomised, double-blind, placebo-controlled trial. The Lancet. https://doi.org/10.1016/s0140-6736(25)01633-2

Source records

crossref · retrieved 2026-09-26T21:48:24.160Z